We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Unifirst Corp
UNF
$5.32B
| $1.4M | ﹤0.01% |
8,498
-1,400
| -14% | -$223K |
|
|
CIO
1402
DELISTED
City Office REIT
CIO
| $1.4M | ﹤0.01% |
107,619
-8,005
| -7% | -$105K |
|
|
WIRE
1403
DELISTED
Encore Wire Corp
WIRE
| $1.4M | ﹤0.01% |
28,678
+13,800
| +93% | +$638K |
|
1404
FreightCar America
RAIL
$275M
| $1.39M | ﹤0.01% |
81,615
+4,100
| +5% | +$70.8K |
|
|
FPRX
1405
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.39M | ﹤0.01% |
63,600
+56,100
| +748% | +$1.8M |
|
|
MYND
1406
Mynd.ai
MYND
$17.6M
| $1.39M | ﹤0.01% |
+8,210
| New | +$1.93M |
|
|
TBI
1407
Trueblue
TBI
$234M
| $1.38M | ﹤0.01% |
50,227
-40,900
| -45% | -$1.08M |
|
1408
St. Joe Company
JOE
$3.57B
| $1.38M | ﹤0.01% |
76,400
+20,700
| +37% | +$383K |
|
1409
Westamerica Bancorp
WABC
$1.39B
| $1.37M | ﹤0.01% |
23,000
-400
| -2% | -$23.5K |
|
1410
UnitedHealth
UNH
$382B
| $1.36M | ﹤0.01% |
6,188
-96,199
| -94% | -$20.4M |
|
|
PHH
1411
DELISTED
PHH Corporation
PHH
| $1.36M | ﹤0.01% |
131,895
-12,165
| -8% | -$148K |
|
1412
Ball Corp
BALL
$17B
| $1.35M | ﹤0.01% |
+35,782
| New | +$1.45M |
|
1413
American Public Education
APEI
$875M
| $1.35M | ﹤0.01% |
53,950
+1,400
| +3% | +$32.6K |
|
|
VEDL
1414
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $1.35M | ﹤0.01% |
64,860
+12,500
| +24% | +$245K |
|
1415
Civeo
CVEO
$379M
| $1.34M | ﹤0.01% |
41,069
+14,062
| +52% | +$387K |
|
|
ROCC
1416
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.34M | ﹤0.01% |
+34,300
| New | +$1.31M |
|
1417
TTEC Holdings
TTEC
$103M
| $1.34M | ﹤0.01% |
33,304
-4,239
| -11% | -$174K |
|
1418
Stellus Capital Investment Corp
SCM
$203M
| $1.33M | ﹤0.01% |
101,345
-1,338
| -1% | -$17.9K |
|
1419
AerCap
AER
$23.9B
| $1.33M | ﹤0.01% |
25,245
-11,100
| -31% | -$578K |
|
|
EMKR
1420
DELISTED
Emcore Corp
EMKR
| $1.33M | ﹤0.01% |
20,585
+1,150
| +6% | +$86.3K |
|
1421
First Citizens BancShares
FCNCA
$24.6B
| $1.32M | ﹤0.01% |
3,272
+200
| +7% | +$80.2K |
|
|
NXTM
1422
DELISTED
NxStage Medical Inc.
NXTM
| $1.32M | ﹤0.01% |
54,412
-170,300
| -76% | -$4.49M |
|
1423
Wabash National
WNC
$543M
| $1.32M | ﹤0.01% |
60,700
-85,900
| -59% | -$1.79M |
|
1424
Heritage Financial
HFWA
$1.24B
| $1.32M | ﹤0.01% |
42,723
-2,600
| -6% | -$80.1K |
|
1425
West Pharmaceutical
WST
$23.1B
| $1.3M | ﹤0.01% |
13,199
-58,600
| -82% | -$5.75M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.